Therapeutic Updates from the ADA 2026 Standards of Care

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review key therapy-focused updates from the 2026 ADA Standards of Care, emphasizing areas they view as practice-changing.Key Episode Timestamps00:00:01 Intro00:00:29 Adding GLP-1 RAs to heart failure00:02:45 GLP-1s in glycemic management00:04:36 Time in range targets in glycemic management00:08:10 ADA recommends GLP-1s for T1D00:12:00 GLP-1s in MASH and MASLD00:12:57 Changes in kidney protection guidelines00:14:40 New therapeutic guidance for T1D and T2D00:17:57 Outro

Episode metadata supplied by the publisher feed · Published Dec 24, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Therapeutic Updates from the ADA 2026 Standards of Care

0:00 18:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 18 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on December 24, 2025.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!